Ebola virus disease complicated with viral interstitial pneumonia: A case report

Nicola Petrosillo; Emanuele Nicastri; Simone Lanini; Maria Rosaria Capobianchi; Antonino Di Caro; Mario Antonini; Vincenzo Puro; Francesco Nicola Lauria; Nakono Shindo; Nicola Magrini; Gary P. Kobinger; Giuseppe Ippolito; Vincenzo Puro; Mario Antonini; Antonio Russo; Antonella Petrecchia; Evangelo Boumis; Marco Gentile; Damiano Travaglini; Silvia Pittalis; Lorena Martini; Concetta Castilletti; Francesco Maria Fusco; Andrea Antinori; Giuseppe Ippolito; Valerio Fabio Alberti; Nazario Bevilacqua; Evangelo Boumis; Stefania Cicalini; Pierangelo Chinello; Angela Corpolongo; Andrea Mariano; Fabrizio Taglietti; Laura Vincenzi; Telma Azevedo; Mario Antonini; Ilaria Caravella; Gabriele Garotto; Luisa Marchioni; Micaela Maritti; Gianni Battisti; Alessanda Coppola; Loredana De Marchis; Nicola De Marco; Fabio Di Gianbattista; Mario Guiducci; Daniela Imola; Antonio Marasco; Antonella Marzolini; Alessandro Mercuri; Paola Nieddu; Silvia Ondedei; Maurizio Vescovo; Laura Vitolo; Elisa Busi Rizzi; Silvia Murachelli; Licia Bordi; Eleonora Lalle; Silvia Meschi; Daniele Lapa; Patrizia Marsella; Francesca Colavita; Roberta Chiappini; Antonio Mazzarelli; Serena Quartu; Chiara Agrati; Fabrizio Carletti; Federica Forbici; Maria Beatrice Valli; Isabella Abbate; Alessandra Amendola; Anna Rosa Garbuglia; Maria Grazia Paglia; Eugenio Bordi; Antonietta Toffoletti; Gaetano Battisti; Marco Liguori; Paolo D'Aprile; Raffaella Barbaro; Lorella Salce; Daniela Renna; Simona Barbato; Paola Vaccaro; Francesco Bianchini

doi:10.1186/s12879-015-1169-4

Ebola virus disease complicated with viral interstitial pneumonia: A case report

Nicola Petrosillo, Emanuele Nicastri, Simone Lanini, Maria Rosaria Capobianchi, Antonino Di Caro, Mario Antonini, Vincenzo Puro, Francesco Nicola Lauria, Nakono Shindo, Nicola Magrini, Gary P. Kobinger, Giuseppe Ippolito, Vincenzo Puro, Mario Antonini, Antonio Russo, Antonella Petrecchia, Evangelo Boumis, Marco Gentile, Damiano Travaglini, Silvia PittalisLorena Martini, Concetta Castilletti, Francesco Maria Fusco, Andrea Antinori, Giuseppe Ippolito, Valerio Fabio Alberti, Nazario Bevilacqua, Evangelo Boumis, Stefania Cicalini, Pierangelo Chinello, Angela Corpolongo, Andrea Mariano, Fabrizio Taglietti, Laura Vincenzi, Telma Azevedo, Mario Antonini, Ilaria Caravella, Gabriele Garotto, Luisa Marchioni, Micaela Maritti, Gianni Battisti, Alessanda Coppola, Loredana De Marchis, Nicola De Marco, Fabio Di Gianbattista, Mario Guiducci, Daniela Imola, Antonio Marasco, Antonella Marzolini, Alessandro Mercuri, Paola Nieddu, Silvia Ondedei, Maurizio Vescovo, Laura Vitolo, Elisa Busi Rizzi, Silvia Murachelli, Licia Bordi, Eleonora Lalle, Silvia Meschi, Daniele Lapa, Patrizia Marsella, Francesca Colavita, Roberta Chiappini, Antonio Mazzarelli, Serena Quartu, Chiara Agrati, Fabrizio Carletti, Federica Forbici, Maria Beatrice Valli, Isabella Abbate, Alessandra Amendola, Anna Rosa Garbuglia, Maria Grazia Paglia, Eugenio Bordi, Antonietta Toffoletti, Gaetano Battisti, Marco Liguori, Paolo D'Aprile, Raffaella Barbaro, Lorella Salce, Daniela Renna, Simona Barbato, Paola Vaccaro, Francesco Bianchini

Research output: Contribution to journal › Article › peer-review

Abstract

Background: In the current Ebola epidemic in Western Africa, many healthcare workers have become infected. Some of these have been medically evacuated to hospitals in Europe and the USA. These clinical experiences provide unique insights into the course of Ebola virus disease under optimized condition within high level isolation units. Case presentation: A 50-year-old Caucasian male physician contracted Ebola virus diseases in Sierra Leone and was medically evacuated to Italy. Few days after the admission the course of the illness was characterized by severe gastro-intestinal symptoms followed by respiratory failure, accompanied by pulmonary infiltration and high Ebola viral load in the bronchial aspirate and Plasmodium vivax co-infection. The patient received experimental antiviral therapy with favipiravir, convalescent plasma and ZMAb. Ebola viral load started to steadily decrease in the blood after ZMAb administration and became undetectable by day 19 after admission, while it persisted longer in urine samples. No temporal association was observed between viral load decay in plasma and administration of favipiravir. The patient completely recovered and was discharged 39days after admission. Conclusions: This is the first case of Ebola-related interstitial pneumonia documented by molecular testing of lung fluid specimens. This reports underlines the pivotal role of fluid replacement and advanced life support with mechanical ventilation in the management of patients with Ebola virus diseases respiratory failure. Beside our finding indicates a close temporal association between administration of cZMAb and Ebola virus clearance from blood.

Original language	English (US)
Article number	432
Journal	BMC Infectious Diseases
Volume	15
Issue number	1
DOIs	https://doi.org/10.1186/s12879-015-1169-4
State	Published - Oct 16 2015
Externally published	Yes

Keywords

Antibodies, monoclonal
Ebola
Favipiravir
Fluid therapy
Hemorrhagic fever
Hospitals, isolation
Immunization, passive
Life support care
Malaria, vivax
Pneumonia, viral

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1186/s12879-015-1169-4

Cite this

Petrosillo, N., Nicastri, E., Lanini, S., Capobianchi, M. R., Di Caro, A., Antonini, M., Puro, V., Lauria, F. N., Shindo, N., Magrini, N., Kobinger, G. P., Ippolito, G., Puro, V., Antonini, M., Russo, A., Petrecchia, A., Boumis, E., Gentile, M., Travaglini, D., ... Bianchini, F. (2015). Ebola virus disease complicated with viral interstitial pneumonia: A case report. BMC Infectious Diseases, 15(1), Article 432. https://doi.org/10.1186/s12879-015-1169-4

Petrosillo, N, Nicastri, E, Lanini, S, Capobianchi, MR, Di Caro, A, Antonini, M, Puro, V, Lauria, FN, Shindo, N, Magrini, N, Kobinger, GP, Ippolito, G, Puro, V, Antonini, M, Russo, A, Petrecchia, A, Boumis, E, Gentile, M, Travaglini, D, Pittalis, S, Martini, L, Castilletti, C, Fusco, FM, Antinori, A, Ippolito, G, Alberti, VF, Bevilacqua, N, Boumis, E, Cicalini, S, Chinello, P, Corpolongo, A, Mariano, A, Taglietti, F, Vincenzi, L, Azevedo, T, Antonini, M, Caravella, I, Garotto, G, Marchioni, L, Maritti, M, Battisti, G, Coppola, A, Marchis, LD, De Marco, N, Gianbattista, FD, Guiducci, M, Imola, D, Marasco, A, Marzolini, A, Mercuri, A, Nieddu, P, Ondedei, S, Vescovo, M, Vitolo, L, Rizzi, EB, Murachelli, S, Bordi, L, Lalle, E, Meschi, S, Lapa, D, Marsella, P, Colavita, F, Chiappini, R, Mazzarelli, A, Quartu, S, Agrati, C, Carletti, F, Forbici, F, Valli, MB, Abbate, I, Amendola, A, Garbuglia, AR, Paglia, MG, Bordi, E, Toffoletti, A, Battisti, G, Liguori, M, D'Aprile, P, Barbaro, R, Salce, L, Renna, D, Barbato, S, Vaccaro, P & Bianchini, F 2015, 'Ebola virus disease complicated with viral interstitial pneumonia: A case report', BMC Infectious Diseases, vol. 15, no. 1, 432. https://doi.org/10.1186/s12879-015-1169-4

@article{efa9e6c9ee0a4db49cc40ac11ed56450,

title = "Ebola virus disease complicated with viral interstitial pneumonia: A case report",

abstract = "Background: In the current Ebola epidemic in Western Africa, many healthcare workers have become infected. Some of these have been medically evacuated to hospitals in Europe and the USA. These clinical experiences provide unique insights into the course of Ebola virus disease under optimized condition within high level isolation units. Case presentation: A 50-year-old Caucasian male physician contracted Ebola virus diseases in Sierra Leone and was medically evacuated to Italy. Few days after the admission the course of the illness was characterized by severe gastro-intestinal symptoms followed by respiratory failure, accompanied by pulmonary infiltration and high Ebola viral load in the bronchial aspirate and Plasmodium vivax co-infection. The patient received experimental antiviral therapy with favipiravir, convalescent plasma and ZMAb. Ebola viral load started to steadily decrease in the blood after ZMAb administration and became undetectable by day 19 after admission, while it persisted longer in urine samples. No temporal association was observed between viral load decay in plasma and administration of favipiravir. The patient completely recovered and was discharged 39days after admission. Conclusions: This is the first case of Ebola-related interstitial pneumonia documented by molecular testing of lung fluid specimens. This reports underlines the pivotal role of fluid replacement and advanced life support with mechanical ventilation in the management of patients with Ebola virus diseases respiratory failure. Beside our finding indicates a close temporal association between administration of cZMAb and Ebola virus clearance from blood.",

keywords = "Antibodies, monoclonal, Ebola, Favipiravir, Fluid therapy, Hemorrhagic fever, Hospitals, isolation, Immunization, passive, Life support care, Malaria, vivax, Pneumonia, viral",

author = "Nicola Petrosillo and Emanuele Nicastri and Simone Lanini and Capobianchi, {Maria Rosaria} and {Di Caro}, Antonino and Mario Antonini and Vincenzo Puro and Lauria, {Francesco Nicola} and Nakono Shindo and Nicola Magrini and Kobinger, {Gary P.} and Giuseppe Ippolito and Vincenzo Puro and Mario Antonini and Antonio Russo and Antonella Petrecchia and Evangelo Boumis and Marco Gentile and Damiano Travaglini and Silvia Pittalis and Lorena Martini and Concetta Castilletti and Fusco, {Francesco Maria} and Andrea Antinori and Giuseppe Ippolito and Alberti, {Valerio Fabio} and Nazario Bevilacqua and Evangelo Boumis and Stefania Cicalini and Pierangelo Chinello and Angela Corpolongo and Andrea Mariano and Fabrizio Taglietti and Laura Vincenzi and Telma Azevedo and Mario Antonini and Ilaria Caravella and Gabriele Garotto and Luisa Marchioni and Micaela Maritti and Gianni Battisti and Alessanda Coppola and Marchis, {Loredana De} and {De Marco}, Nicola and Gianbattista, {Fabio Di} and Mario Guiducci and Daniela Imola and Antonio Marasco and Antonella Marzolini and Alessandro Mercuri and Paola Nieddu and Silvia Ondedei and Maurizio Vescovo and Laura Vitolo and Rizzi, {Elisa Busi} and Silvia Murachelli and Licia Bordi and Eleonora Lalle and Silvia Meschi and Daniele Lapa and Patrizia Marsella and Francesca Colavita and Roberta Chiappini and Antonio Mazzarelli and Serena Quartu and Chiara Agrati and Fabrizio Carletti and Federica Forbici and Valli, {Maria Beatrice} and Isabella Abbate and Alessandra Amendola and Garbuglia, {Anna Rosa} and Paglia, {Maria Grazia} and Eugenio Bordi and Antonietta Toffoletti and Gaetano Battisti and Marco Liguori and Paolo D'Aprile and Raffaella Barbaro and Lorella Salce and Daniela Renna and Simona Barbato and Paola Vaccaro and Francesco Bianchini",

note = "Publisher Copyright: {\textcopyright} 2015 Petrosillo et al.",

year = "2015",

month = oct,

day = "16",

doi = "10.1186/s12879-015-1169-4",

language = "English (US)",

volume = "15",

journal = "BMC Infectious Diseases",

issn = "1471-2334",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Ebola virus disease complicated with viral interstitial pneumonia

T2 - A case report

AU - Petrosillo, Nicola

AU - Nicastri, Emanuele

AU - Lanini, Simone

AU - Capobianchi, Maria Rosaria

AU - Di Caro, Antonino

AU - Antonini, Mario

AU - Puro, Vincenzo

AU - Lauria, Francesco Nicola

AU - Shindo, Nakono

AU - Magrini, Nicola

AU - Kobinger, Gary P.

AU - Ippolito, Giuseppe

AU - Puro, Vincenzo

AU - Antonini, Mario

AU - Russo, Antonio

AU - Petrecchia, Antonella

AU - Boumis, Evangelo

AU - Gentile, Marco

AU - Travaglini, Damiano

AU - Pittalis, Silvia

AU - Martini, Lorena

AU - Castilletti, Concetta

AU - Fusco, Francesco Maria

AU - Antinori, Andrea

AU - Ippolito, Giuseppe

AU - Alberti, Valerio Fabio

AU - Bevilacqua, Nazario

AU - Boumis, Evangelo

AU - Cicalini, Stefania

AU - Chinello, Pierangelo

AU - Corpolongo, Angela

AU - Mariano, Andrea

AU - Taglietti, Fabrizio

AU - Vincenzi, Laura

AU - Azevedo, Telma

AU - Antonini, Mario

AU - Caravella, Ilaria

AU - Garotto, Gabriele

AU - Marchioni, Luisa

AU - Maritti, Micaela

AU - Battisti, Gianni

AU - Coppola, Alessanda

AU - Marchis, Loredana De

AU - De Marco, Nicola

AU - Gianbattista, Fabio Di

AU - Guiducci, Mario

AU - Imola, Daniela

AU - Marasco, Antonio

AU - Marzolini, Antonella

AU - Mercuri, Alessandro

AU - Nieddu, Paola

AU - Ondedei, Silvia

AU - Vescovo, Maurizio

AU - Vitolo, Laura

AU - Rizzi, Elisa Busi

AU - Murachelli, Silvia

AU - Bordi, Licia

AU - Lalle, Eleonora

AU - Meschi, Silvia

AU - Lapa, Daniele

AU - Marsella, Patrizia

AU - Colavita, Francesca

AU - Chiappini, Roberta

AU - Mazzarelli, Antonio

AU - Quartu, Serena

AU - Agrati, Chiara

AU - Carletti, Fabrizio

AU - Forbici, Federica

AU - Valli, Maria Beatrice

AU - Abbate, Isabella

AU - Amendola, Alessandra

AU - Garbuglia, Anna Rosa

AU - Paglia, Maria Grazia

AU - Bordi, Eugenio

AU - Toffoletti, Antonietta

AU - Battisti, Gaetano

AU - Liguori, Marco

AU - D'Aprile, Paolo

AU - Barbaro, Raffaella

AU - Salce, Lorella

AU - Renna, Daniela

AU - Barbato, Simona

AU - Vaccaro, Paola

AU - Bianchini, Francesco

PY - 2015/10/16

Y1 - 2015/10/16

N2 - Background: In the current Ebola epidemic in Western Africa, many healthcare workers have become infected. Some of these have been medically evacuated to hospitals in Europe and the USA. These clinical experiences provide unique insights into the course of Ebola virus disease under optimized condition within high level isolation units. Case presentation: A 50-year-old Caucasian male physician contracted Ebola virus diseases in Sierra Leone and was medically evacuated to Italy. Few days after the admission the course of the illness was characterized by severe gastro-intestinal symptoms followed by respiratory failure, accompanied by pulmonary infiltration and high Ebola viral load in the bronchial aspirate and Plasmodium vivax co-infection. The patient received experimental antiviral therapy with favipiravir, convalescent plasma and ZMAb. Ebola viral load started to steadily decrease in the blood after ZMAb administration and became undetectable by day 19 after admission, while it persisted longer in urine samples. No temporal association was observed between viral load decay in plasma and administration of favipiravir. The patient completely recovered and was discharged 39days after admission. Conclusions: This is the first case of Ebola-related interstitial pneumonia documented by molecular testing of lung fluid specimens. This reports underlines the pivotal role of fluid replacement and advanced life support with mechanical ventilation in the management of patients with Ebola virus diseases respiratory failure. Beside our finding indicates a close temporal association between administration of cZMAb and Ebola virus clearance from blood.

AB - Background: In the current Ebola epidemic in Western Africa, many healthcare workers have become infected. Some of these have been medically evacuated to hospitals in Europe and the USA. These clinical experiences provide unique insights into the course of Ebola virus disease under optimized condition within high level isolation units. Case presentation: A 50-year-old Caucasian male physician contracted Ebola virus diseases in Sierra Leone and was medically evacuated to Italy. Few days after the admission the course of the illness was characterized by severe gastro-intestinal symptoms followed by respiratory failure, accompanied by pulmonary infiltration and high Ebola viral load in the bronchial aspirate and Plasmodium vivax co-infection. The patient received experimental antiviral therapy with favipiravir, convalescent plasma and ZMAb. Ebola viral load started to steadily decrease in the blood after ZMAb administration and became undetectable by day 19 after admission, while it persisted longer in urine samples. No temporal association was observed between viral load decay in plasma and administration of favipiravir. The patient completely recovered and was discharged 39days after admission. Conclusions: This is the first case of Ebola-related interstitial pneumonia documented by molecular testing of lung fluid specimens. This reports underlines the pivotal role of fluid replacement and advanced life support with mechanical ventilation in the management of patients with Ebola virus diseases respiratory failure. Beside our finding indicates a close temporal association between administration of cZMAb and Ebola virus clearance from blood.

KW - Antibodies, monoclonal

KW - Ebola

KW - Favipiravir

KW - Fluid therapy

KW - Hemorrhagic fever

KW - Hospitals, isolation

KW - Immunization, passive

KW - Life support care

KW - Malaria, vivax

KW - Pneumonia, viral

UR - http://www.scopus.com/inward/record.url?scp=84944871744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944871744&partnerID=8YFLogxK

U2 - 10.1186/s12879-015-1169-4

DO - 10.1186/s12879-015-1169-4

M3 - Article

C2 - 26471197

AN - SCOPUS:84944871744

SN - 1471-2334

VL - 15

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

IS - 1

M1 - 432

ER -

Ebola virus disease complicated with viral interstitial pneumonia: A case report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this